Kyruus is a provider of enterprise search and scheduling solutions that help health systems match patients with the right providers across points of access.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/15/2022 | Series E | $35.1MM | $xx.xx | $359.84MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,499,997
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
01/08/2020 | Series D | $72.35MM | $xx.xx | $299.96MM | Highland Capital Partners, Providence Ventures, Salesforce Ventures, Venrock | |
Price per Share
$xx.xx
Shares Outstanding
3,184,415
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Highland Capital Partners, Providence Ventures, Salesforce Ventures, Venrock
|
||||||
12/06/2019 | Series C | $65.37MM | $xx.xx | $142.09MM | F-Prime Capital, Highland Capital Partners, Leerink Partners, Lux Capital, Mckesson Ventures, New Leaf Venture Partners, Providence Health & Services, Venrock | |
Price per Share
$xx.xx
Shares Outstanding
4,239,031
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
F-Prime Capital, Highland Capital Partners, Leerink Partners, Lux Capital, Mckesson Ventures, New Leaf Venture Partners, Providence Health & Services, Venrock
|
||||||
12/21/2012 | Series B | $11.11MM | $xx.xx | $44.48MM | Fidelity Biosciences, F-Prime Capital, Highland Capital Partners, Lux Capital, Venrock | |
Price per Share
$xx.xx
Shares Outstanding
1,026,791
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Fidelity Biosciences, F-Prime Capital, Highland Capital Partners, Lux Capital, Venrock
|
||||||
10/24/2011 | Series A-1 | $3.1MM | $xx.xx | $16.59MM | Eight Roads Ventures | |
Price per Share
$xx.xx
Shares Outstanding
361,727
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Eight Roads Ventures
|
||||||
05/31/2011 | Series A | $5.5MM | $xx.xx | $11MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,283,644
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|